Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas

Fertility and Sterility

Volumn 90, Issue 1, 2008, Pages 165-173

  Palomba, Stefano ^a   Orio Jr , Francesco ^b   Falbo, Angela ^a   Oppedisano, Rosamaria ^a   Tolino, Achille ^c   Zullo, Fulvio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cognition; GnRH a; leuprolide acetate; mood; SNC; tibolone

Indexed keywords

LEUPRORELIN; PLACEBO; TIBOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENORRHAGIA; MOOD; NEUROPSYCHOLOGICAL TEST; PELVIC DISEASE; PELVIS PAIN SYNDROME; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT RESPONSE; URINARY FREQUENCY; UTERUS MYOMA;

ADMINISTRATION, ORAL; ADULT; AFFECT; ANTINEOPLASTIC AGENTS, HORMONAL; CENTRAL NERVOUS SYSTEM AGENTS; COGNITION; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LEIOMYOMA; LEUPROLIDE; MIDDLE AGED; NORPREGNENES; QUALITY OF LIFE; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 45849113688     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.05.061     Document Type: Article

References (61)

1. Kappy M., Stuart T., Perelman A., and Clemons R. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty. J Clin Endocrinol Metab 69 (1989) 1087-1089
2. Kletter G.B., and Kelch R.P. Clinical review 60: effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 79 (1994) 331-334
3. Castiglione-Gertsch M., O'Neill A., Price K.N., Goldhirsch A., Coates A.S., Colleoni M., et al. International Breast Cancer Study Group. Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 95 (2003) 1811-1812
4. Broekmans F.J. GnRH agonists and uterine leiomyomas. Hum Reprod 11 Suppl 3 (1996) 3-25
5. Venturini P.L., Fasce V., Costantini S., Anserini P., Cucuccio S., and de Cecco L. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results. Fertil Steril 54 (1990) 1021-1027
6. Di Carlo C., Palomba S., Tommaselli G.A., Guida M., Di Spiezio Sardo A., and Nappi C. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 75 (2001) 380-384
7. Adashi E.Y. Long-term gonadotropin releasing hormone agonist therapy: the evolving issue of steroidal "add-back" paradigms. Hum Reprod 9 (1994) 1380-1397
8. Kortepeter C., Macmillan M., and Ferrell R. Possible short-term memory loss associated with nafarelin acetate. Ann Pharmacother 26 (1992) 169-171
9. Varney N.R., Syrop C., Kubu C.S., Struchen M., Hahn S., and Franzen K. Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet 10 (1993) 53-57
10. Sherwin B.B., and Tulandi T. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81 (1996) 2545-2549
11. Newton C., Slota D., Yuzpe A.A., and Tummon I.S. Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertil Steril 5 (1996) 1253-1255
12. Warnock J.K., and Bundren J.C. Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy. Psychopharmacol Bull 33 (1997) 311-316
13. Warnock J.K., Bundren J.C., and Morris D.W. Depressive symptoms associated with gonadotropin-releasing hormone agonists. Depress Anxiety 7 (1998) 171-177
14. Palomba S., Orio Jr. F., Russo T., Falbo A., Amati A., and Zullo F. Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life. Fertil Steril 82 (2004) 480-482
15. Grigorova M., Sherwin B.B., and Tulandi T. Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women. Psychoneuroendocrinology 31 (2006) 935-947
16. Palomba S., Affinito P., Tommaselli G.A., and Nappi C. A clinical trial on the effects of tibolone association with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata. Fertil Steril 70 (1998) 111-118
17. Palomba S., Affinito P., Di Carlo C., Bifulco G., and Nappi C. Long-term administration of tibolone plus GnRH-a in the treatment of uterine leiomyomata on effectiveness, vasomotor symptoms, bone mass and lipid profile. Fertil Steril 72 (1999) 889-895
18. Palomba S., Pellicano M., Affnito P., Di Carlo C., Zullo F., and Nappi C. Effectiveness of short-term administration of tibolone plus gonadotropin releasing hormone analogue on the surgical outcome of laparoscopic myomectomy. Fertil Steril 75 (2001) 429-433
19. Palomba S., Morelli M., Di Carlo C., Noia R., Pellicano M., and Zullo F. Bone metabolism in postmenopausal women who have been treated with a gonadotropin-releasing hormone agonist and tibolone. Fertil Steril 78 (2002) 63-68
20. Albertazzi P., Natale V., Barbolini C., Teglio L., and Di Micco R. The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study. Maturitas 31 (2000) 223-229
21. Huber J., Palacios S., Berglund L., Hanggi W., Sathanandan S.M., Christau S., et al. Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women. BJOG 109 (2002) 886-893
22. Onalan G., Onalan R., Selam B., Akar M., Gunenc Z., and Topcuoglu A. Mood scores in relation to hormone replacement therapies during menopause: a prospective randomized trial. Tohoku J Exp Med 207 (2005) 223-231
23. Baksu A., Ayas B., Citak S., Kalan A., Baksu B., and Goker N. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause. Int J Gynaecol Obstet 91 (2005) 58-62
24. Liu J.H. Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms. Am J Med 118 (2005) 88-92
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
26. Spitzer R.L., Williams J.B.W., Gibbon M., and Willams J.B.M. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version: user's guide (1996), American Psychiatric Association Press, Washington, DC
27. Palomba S., Orio Jr. F., Morelli M., Russo T., Pellicano M., Nappi C., et al. Raloxifene administration in women treated with gonadotropin releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. J Clin Endocrinol Metab 87 (2002) 4476-4481
28. Kupperman H.S., Blat M.H.G., Wiesbader H., and Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol 13 (1953) 688-703
29. Conti L. Repertorio delle scale di valutazione in psichiatria (1999), Società Editrice Europea, Florence, Italy
30. Wechsler D.A. A standardized memory scale for clinical use. J Psychol 19 (1945) 87-95
31. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
32. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-63
33. Zung W.W.K. A rating instrument for anxiety disorders. Psychosomatics 12 (1971) 371-379
34. Apolone G., and Mosconi P. The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51 (1998) 1025-1036
35. Genazzani A.R., Nicolucci A., Campagnoli C., Crosignani P., Nappi C., Serra G.B., et al. Validation of Italian version of the Women's Health Questionnaire: assessment of quality of life of women from the general population and those attending menopause centers. Climacteric 5 (2002) 70-77
36. Ware J.E., Snow K.K., Kosinski M., and Gandek B. SF-36 Health Survey manual and interpretation guide (1993), The Health Institute, New England Medical Center, Boston, MA
37. Wiklund I., Holst J., Karlberg J., Mattsson L.A., Samsioe G., Sandin K., et al. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 14 (1992) 211-224
38. Egger M., Juni P., Bartlett C., and CONSORT Group(Consolidated Standards of Reporting of Trials). Value of flow diagrams in reports of randomized controlled trials. JAMA 285 (2001) 1996-1999
39. McEwen B.S., and Alves S.E. Estrogen actions in the central nervous system. Endocr Rev 20 (1999) 279-307
40. Genazzani A.R., Pluchino N., Luisi S., and Luisi M. Estrogen, cognition and female ageing. Hum Reprod Update 13 (2007) 175-187
41. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13 (1988) 345-357
42. Phillips S.M., and Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17 (1992) 485-495
43. Sherwin B.B. Estrogen and cognitive functioning in surgically menopausal women. Ann NY Acad Sci 592 (1990) 474-475
44. Binder E.F., Schechtman K.B., Birge S.J., Williams D.B., and Kohrt W.M. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 38 (2001) 137-146
45. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2947-2958
46. Sherwin B.B. Estrogen and cognitive aging in women. Neuroscience 138 (2006) 1021-1026
47. Friedman A.J., Daly M., Juneau-Norcross M., Gleason R., Rein M.S., and LeBoff M. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin "add-back" for 2 years. Hum Reprod 9 (1994) 1618-1625
48. Palomba S., Falbo A., Russo T., and Zullo F. GnRH analogs for the treatment of symptomatic uterine leiomyomas. Gynecol Surg 2 (2005) 7-13
49. Palomba S., Russo T., Orio Jr. F., Tauchmananovà L., Zupi E., Benedetti Panici P.G., et al. Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Hum Reprod 17 (2002) 3213-3219
50. Palomba S., Russo T., Orio Jr. F., Sammartino A., Sbano F.M., Nappi C., et al. Lipid, glucose, and homocysteine metabolism in women treated with a gonadotropin-releasing hormone agonist with or without raloxifene. Hum Reprod 19 (2004) 415-421
51. Yaffe K., Krueger K., Sarkar S., Grady D., Barrett-Connor E., Cox D.A., et al. Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 344 (2001) 1207-1213
52. de Gooyer M.E., Deckers G.H., Schoonen W.G., Verheul H.A., and Kloosterboer H.J. Receptor profiling and endocrine interactions of tibolone. Steroids 68 (2003) 21-30
53. Castelo-Branco C., Garcia-Fantini M., and Haya J. Vascular reactivity and atheromatous plaques in post-menopausal women on tibolone treatment. Open prospective study with Doppler ultrasonography in internal carotid artery. Maturitas 50 (2005) 259-265
54. Lund C.O., Nilas L., Dalsgaard T., Pedersen S.H., and Ottesen B. Acute effects of tibolone on cerebral vascular reactivity in vitro. Climacteric 6 (2003) 228-237
55. Pan H.A., Wang S.T., Chen C.H., Pai M.C., Wu M.H., and Huang K.E. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy. Climacteric 5 (2002) 259-265
56. Gibbs R.B., Edwards D., Lazar N., Nelson D., and Talameh J. Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys. J Neuroendocrinol 18 (2006) 643-654
57. Modelska K., and Cummings S. Tibolone for postmenopausal women: systematic review of randomized trials. J Clin Endocrinol Metab 87 (2002) 16-23
58. Taskin O., Yalcinoglu A.I., Kucuk S., Uryan I., Buhur A., and Burak F. Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis. Fertil Steril 67 (1997) 40-45
59. Verheul H.A., and Kloosterboer H.J. Metabolism of exogenous sex steroids and effect on brain functions with a focus on tibolone. J Steroid Biochem Mol Biol 102 (2006) 195-204
60. Genazzani A.R., Petraglia F., and Facchinetti F. Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women. Maturitas Suppl 1 (1987) 35-48
61. Genazzani A.R., Bernardi F., Pluchino N., Giretti M.S., Begliuomini S., Casarosa E., et al. Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats. Menopause 13 (2006) 57-64